Teri returned to Indiana in 2018 to join Indiana University as an Executive Director of IU Ventures and to launch and manage the new Indiana Philanthropic Venture Fund. She is a member of the IU Ventures Board and Investment Committee; Dimension Mill/Velocities Investment Committee; a Director of the Venture Club of Indiana, a Director of portfolio companies NERx Biosciences, Diagnotes and Periodic, and an Advisor to OnCode Institute in the Netherlands.
Her career has been about starting and re-organizing university technology transfer programs and launching new early stage funds that invest in university science based ventures.
Teri served as Vice President of Cold Spring Harbor Laboratory leading a new program for industry engagement, new ventures and intellectual property licensing; Vice President for Technology and Business Development for Mount Sinai School of Medicine; founding Chief Executive of Cambridge Enterprise, Ltd the technology commercialization affiliate of the University of Cambridge in England; founder and Managing Partner of ARCH Development Partners (ADP), a seed and early stage venture fund focused on university and corporate spin-outs; Business Development for Endocyte, Inc., University of Notre Dame Business School Adjunct Faculty; and Vice President of Start-ups at ARCH Development Corporation, a subsidiary of the University of Chicago, which commercialized technology from the University and Argonne National Laboratory. Her prior experience also includes non-executive board positions with a several early stage companies, technology transfer leadership roles at Northwestern University and Purdue Research Foundation, founding membership on the Indiana 21st Century Fund Board and business development for International Minerals and Chemical.
Teri has been an advisor to policy makers, universities and companies, is a past President of the Association of University Technology Managers (AUTM), a former Bye Fellow of Christ’s College Cambridge in England and a Sagamore of the Wabash.